Evommune, Inc. · NYSE:EVMN
Ra Capital Management, L.P. reported a 9.70% stake in Evommune, Inc. (Schedule 13D/A)
Event Feb 12, 2026 · Filed Feb 17, 2026
Ra Capital Management, L.P. reported a 9.70% stake in Evommune, Inc., 3,494,638 shares, with active intent on Feb 12, 2026. Filed Feb 17, 2026 (Schedule 13D/A).
- Stake
- 9.70%
- Shares
- 3,494,638
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.70% | 3,494,638 |
| Peter Kolchinsky | 9.70% | 3,494,638 |
| Rajeev Shah | 9.70% | 3,494,638 |
| RA Capital Healthcare Fund, L.P. | 7.50% | 2,710,293 |
Source
Related
- Evommune, Inc.
- Ra Capital Management, L.P.
- Evommune, Inc. shareholders
- Schedule 13D · Ra Capital Management, L.P. · Nov 17, 2025
- Form 4 · Pena Luis C. · Oct 15, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Andera Partners · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Carver Kyle · Jul 10, 2026